3623 results for «2460»
3623 results
EAPCI-PCR Fellows Course 2021 - Coronary track: Ambiguous LM/PCI strategy for mid-LAD bifurcation
14 Apr 2021 – From EuroPCR 2021
The best PCI strategies for an ambiguous LM, then a mid-LAD bifurcation. With golden tips from G. Stankovic and T. Lefèvre!
The EAPCI-PCR Fellows Course is a project supported by the New Initiatives For Young Interventionalists Committee (NIFYI) and PCR NextGen, and is intended for practitioners at...
EAPCI-PCR Fellows Course 2021 - Coronary track: Interventions for calcified coronary lesions
14 Apr 2021 – From EuroPCR 2021
The role of imaging for procedural planning and the best indications for specific plaque modification techniques!
The EAPCI-PCR Fellows Course is a project supported by the New Initiatives For Young Interventionalists Committee (NIFYI) and PCR NextGen, and is intended for practitioners at the beginning of their careers....
EuroPCR 2021 Clinical Research - Waiting for FUTURE II, a randomised trial of a novel, thin-strut bioresorbable scaffold
14 Apr 2021 – From EuroPCR 2021
Will thinner struts breathe new life into the bioresorbable scaffolds ? Follow this PCR Clinical Research episode to find out more about the latest BRS technology!
PCR Clinical Research - Late breaking science at EuroPCR 2021: appraising the methods, while awaiting the results.
EuroPCR 2021 - Innovations in mitral valve replacement and repair
18 May 2021 – From EuroPCR 2021
In this session, get a clear presentation of the SATURN device, its procedure and its early results, and a good demonstration of the successful transseptal deployment of this implant in the acute porcine model.
EuroPCR 2021 - Innovations in chronic heart failure
18 May 2021 – From EuroPCR 2021
This session will provide you with 90-day outcomes of a novel no-implant interatrial shunt first in human trial, six-month outcomes of transcatheter LV restoration in heart failure patients, and mid-term results of hybrid LV reconstruction in ischemic HFrEF.
A low-risk patient with a bicuspid type 0 aortic stenosis
18 May 2021 – From EuroPCR 2021
How would you treat an 82-year-old male patient presented with dyspnoea NYHA III who is also found to have IPMN? View this session to analyze the authors' decision!
Two emergencies in one time
18 May 2021 – From EuroPCR 2021
What happened to this 47-year-old man who was still restless, hypoxic, tachypenic, and dependent on oxygen and inotrope even after excellent PCI results? Watch this session to find out more!
Acute STEMI, coronary ectasia and large thrombus burden
18 May 2021 – From EuroPCR 2021
In this session, discover why the combination of DOAC's and DAPT have promising role in the management of large thrombus and coronary ectasia.
Sailing in between the devil and the deep blue sea
18 May 2021 – From EuroPCR 2021
In this session, conduct a reflection on dislodged stents and the best way to deal with such a problem.
Culotte stenting for the treatment of unprotected distal LM with compromised Lcx ostium: the difficulty to cross stents cell with balloons
18 May 2021 – From EuroPCR 2021
In this session, analyze culotte stenting in patient with significant distal left main stenosis.
A broken arm swinging in the heart 15 years after transcatheter PFO closure
18 May 2021 – From EuroPCR 2021
This session leads us to question the risks of device arm fracture and to seek the best therapeutic strategies to address these problems.
LM trifurcation STEMI
18 May 2021 – From EuroPCR 2021
Watch the case of this 69-year-old male patient suffering from LM trifurcation with sub-occlusive lesion who presented with severe bradycardia and hypotension after angios: would you have treated him the same way?
Complex treatment of the post MI ventricular septal defect
18 May 2021 – From EuroPCR 2021
This sessions aims at showing why and how percutaneous occlusion of post MI ventricular septal defect can be a feasible alternative approach for patients who are unsuitable for cardiac surgery.
How to treat an occluded radial artery graft
18 May 2021 – From EuroPCR 2021
Watch this session and you will understand why it is essential to always consider revascularization of native vessels once patients are stented in either vein or arterial grafts.
When nightmares become real
18 May 2021 – From EuroPCR 2021
In this session, study the delicate case of a patient facing 3 possible treatment scenarios and find out what the doctor's choice is, and why. CABG, PCI left system first and then RCA, or reverse: would you have chosen the same option?
A young patient with excruciating chest pain and extensive complications
18 May 2021 – From EuroPCR 2021
Try to find out what happens to the presented patient, only 34 years old: spasm, ACS, STEMI occluded diagonal culprit lesion, or spontaneous dissection causing occlusion of diagonal branch? And ask yourself what you would do in such a case!
Exclusion of a huge symptomatic coronary-cameral fistulae
18 May 2021 – From EuroPCR 2021
In this session, find out more about CCF, a rare but major congenital anomaly with potential serious complications undergoing in the older patients.
Treating complex coronary lesions: right case right time Prevail™ DCB
01 Oct 2021 – From AICT-AsiaPCR 2021
Thanks to this session, find out more about indications for drug-coated balloons, or, on the contrary, learn when not to use it. And through the analysis of two concrete cases, see how DCB can be an important tool to tackle increasingly complex patients and anatomies, especially...
Telescope guide extension catheter in complex coronary interventions
01 Oct 2021 – From AICT-AsiaPCR 2021
View the complex case of this 70-year-old male patient with hypertension and diabetes who presented with chest pain and NSTEMI, which shows that, when dealing with challenging calcific disease, guide catheter extensions help improve device delivery.
MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients
01 Oct 2021 – From AICT-AsiaPCR 2021
In this session dedicated to the MASTER DAPT study, considered the largest HBR trial to date, learn about the baseline characteristics, clinical presentation, and procedural characteristics of this large trial carried out across 4 continents, before hearing our speakers' interpretation of its 30-days outcomes.
